files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in

Research Journal of Medical Sciences, Volume 17, Issue 7 (2023)

References

  1. Kattan, J., F.E. Karak, F. Farhat, D.A. Gerges and W. Mokaddem et al., 2022. Prevalence of HER2-neu status and its clinicopathological association in newly diagnosed gastric cancer patients. BMC. Cancer., 22: 11-14.
  2. Kasochi, C., P. Julius, I. Mweemba and V. Kayamba, 2020. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the university teaching hospital, lusaka, zambia. Afr. Health. Sci., 20: 1857-1864.
  3. Azam, M., F. Akhtar, M. Shams and H. Ahmad, 2017. Immunohistochemical expression of human epiderman growth factor receptor-2 in gastric adenocarcinomana in Pakistan. Pak. Med. Forces. Med. J., Vol. 67..
  4. Hussein, A.A., R. Emily, T.M. Omulo and P.L.W. Ndaguatha, 2014. HER2/neu protein over-expression in patients with gastric and gastro: Esophageal junction carcinoma seen at Kenyatta national hospital, Kenya. J. Carcinogenesis. Mutagen., Vol. 5. 10.4172/2157-2518.1000186.
  5. Abbasi, M.M.H., E. Jafari, M.J. Zahedi, S.D. Moghaddam and N.N.T. Zarandi, 2019. Association between HER2/Neu overexpression in gastric adenocarcinoma and histopathologic features of tumor in gastrectomy samples: A cross-sectional study in Kerman, Iran. J. Uni. Med. Sci., 26: 177-184.
  6. Kermani, A.T., R. Vakili, S. Dadkhah, A.H. Jafarian and R. Bagheri, 2016. HER2/neu overxpression in esophageal squamous cell carcinoma (ESCC) and its correlation with patient’s clinicopathological features. Iran. J. Cancer. Prev., Vol. 9. 10.17795/ijcp-5007.
  7. Ahmed, A. and D.M. Al-Tamimi, 2018. Incorporation of P-53 mutation status and Hi-67 proliferating index in classifying HER2-Neu positive gastric adenocarcinoma. Libyan. J. Med., Vol. 13, 1. 10.1080/19932820.2018.1466573.
  8. Lashkarizadeh, M., M. Lashkarizadeh, M. Nikian and M.K. Parizi, 2023. The expression of HER2/Neu in patients with lung cancer and its associated factors. Clin. Respir. J., 17: 90-95.
  9. Saranya, S. Prabha, S. Bantumilli and M. Chandrasekar, 2022. Significance of HER2/Neu expression in oesophageal carcinomas and its association with the histopathological grading. J. Clanical. Diagnostic Res., Vol. 16, 9. 10.7860/jcdr/2022/54890.16851.
  10. Jafari, E., S. Safinejad, S. Dabir and A. Naghibzadeh-Tahami, 2021. Study of the relationship between MMP-2 and MMP-9 and HER2/neu overexpression in gastric cancer: Clinico- pathological correlations. Asian. Pac. J. Cancer Prev., 22: 811-817.
  11. Swami, R.M., B.N. Patel, R. Lakhe and R. Nimbargi, 2021. Study of prognostic indicators and HER2neu expression in gastric adenocarcinomas: A tertiary care centre study. Indian. J. Pathol. Oncol., 8: 104-110.
  12. Haque, S., R.K. Dewan, S. Saleh, S.A. Jennah and F. Jahan et al., 2018. Histomorphological study of urinary bladder tumor and status of HER2/Neu and Ki67 expression in urothelial carcinoma. J. Histopathol. Cytopathol., 2: 99-108.
  13. Jafri, A. and S. Rizvi, 2017. Frequency of HER2/Neu protein expression in ovarian epithelial cancers. J. Coll. Physicians. Surg. Pak. 27: 544-546.
  14. Carlt, D.M.D., M.P. da Rocha, L.C.M. Antunes and R.B. Fagundes, 2015. Immunohistochemical expression of HER2 in adenocarcinoma of the stomach. Arquivos. Gastroenterologia., 52: 152-155.
  15. Sarmadi, S., N. Izadi-Mood, N. Mansourzadeh and D. Motevalli, 2019. Evaluation of HER2/neu expression in high-grade endometrial carcinoma and its clinicopathological correlation. Iran. J. Pathol., 14: 322-328.
  16. Dipsikha, C., G. Sanchita, J. Bhawna, G. Saurav and N. Ayandip, 2022. HER2neu expression of gastric and lower esophageal carcinoma and its correlation with clinicopathological findings in tertiary care hospital in eastern India. Biomed. Biotechnol. Res. J., 6: 203-207.
  17. Haque, S., R.K. Dewan, S. Saleh, S.A. Jennah and F. Jahan, 2018. Histomorphological study of urinary bladder tumor and status of HER2/Neu and Ki67 expression in urothelial carcinoma. J. Histopathol. Cytopathol., 2: 99-108.
  18. Shandiz, F.H., S. Kadkhodayan, K. Ghaffarzadegan, H. Esmaeily, S. Torabi and S.A. Khales, 2016. The impact of P16 and HER2 expression on survival in patients with ovarian carcinoma. Neoplasma, 63: 816-821.
  19. Alvarado-Cabrero, I., S. Gil-Hernández, A. Ruelas-Perea, D. Villaverde-Rodríguez, J.R. Montes-Ochoa and R. Medrano-Guzmán, 2017. Evaluación por inmunohistoquímica de la expresión del HER2 en cáncer gástrico. Estudio clínico-patológico de 93 casosImmunohistochemical assessment of HER2 expression in gastric cancer. A clinicopathologic study of 93 cases. Cirugía Cirujanos, 85: 504-509.
  20. Jain, P., N. Wadhwa, P. Diwaker, M. Joshi and K. Mishra, 2023. Alteration in key oncoprotein expression in gastric adenocarcinoma-an immunohistochemical study. J. Cancer Res. Ther., 19:.
  21. Zafar, G., S. Afzal, A. Zafar and S. Zaman, 2020. Gallbladder adenocarcinoma, potential target for anti-her-2 therapy. Acta Medica Iranica, 10: 234-239.